AIM ImmunoTech Inc. (AIM)
NYSE: AIM · Biological Products, (No Diagnostic Substances) · Ocala, FL · filing with the SEC since 1996
Filings
511 filings since 2017 beside 307 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Sep 30, 2026.
Filings a yearinsider forms included
129484965601198073
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Jun 20, 2025.Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Feb 26, 2025.SEC letters: 30 in the last 36 months, the newest Jun 18, 2026.A late-filing notice, Form NT 10-Q, filed Nov 17, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 14, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Sep 8, 2026
Sep 10, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Sep 3, 2026
Sep 4, 2026
8-K items 1.01, 1.02, 3.02, 9.01
Major agreement signed; Major agreement ended; Shares sold without registration · Current report
Aug 31, 2026
Aug 6, 2026
8-K items 1.01, 5.08, 9.01
Major agreement signed; item 5.08 · Current report
Jul 31, 2026
Jun 11, 2026
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
Jun 9, 2026
May 21, 2026
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
May 20, 2026
May 19, 2026
8-K items 1.01, 2.02, 2.03, 7.01, 9.01
Major agreement signed; Results released; New debt or obligation taken on; Investor disclosure (Regulation FD) · Current report
May 18, 2026
40 of 511 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.